Interview with Oscar Salamanca, CEO of APICES

by Egle Pavyde | Feb 6, 2026 | News

On integration, change leadership, and strengthening Apices as one unified organization  In a clinical research environment where sponsors value stability, predictability, and quality above all else, organizational change must be approached with care. As APICES...

Real-World Evidence and Health Economics and Outcomes Research: From Nice to Have to Non-Negotiable

by Bilyana Petrova | Dec 11, 2025 | News

Over the past few years, real-world evidence (RWE) and health economics and outcomes research (HEOR) have shifted from supporting roles to central levers in how pharma designs trials, secures access, and manages the lifecycle of medicines. Regulators are formalising...

APICES Acknowledged for its Role in GEOCP-SEOR Study 

by Bilyana Petrova | Dec 2, 2025 | News

APICES CRO is pleased to announce its contribution to the GEOCP-SEOR study. This is a RWE Study in Non Small Cell Lung Cancer (NSCLC), recently featured in the Cancers Journal.  The study evaluates and provide real-world...

How Artificial Intelligence Is Transforming Drug Development in Europe 

by Bilyana Petrova | Nov 10, 2025 | News

Insights from Óscar Salamanca, CEO of APICES, President of the Spanish Association of Clinical Research Companies (AECIC)  Artificial intelligence (AI) is transforming the landscape of clinical research and drug development. From predictive analytics and trial...

Key takeaways from ESMO Congress 2025 in Berlin

by Bilyana Petrova | Oct 29, 2025 | News

The 2025 edition of the European Society for Medical Oncology (ESMO) Congress, held in Berlin from October 17-21, offered a wealth of data and signals for the evolving landscape of oncology clinical research. For executives in Pharma and Biotech focused on...

APICES Acknowledged for its Role in CANTABRICO Clinical Trial 

by Bilyana Petrova | Oct 22, 2025 | News

APICES CRO is pleased to announce its contribution to the CANTABRICO study. This is a Phase IIIb clinical trial in Small Cell Lung Cancer (SCLC), recently featured in the Elsevier Lung Cancer Journal.  The study evaluates first-line treatment in...